- Home
- INSG vs MIST Comparison
INSG vs MIST Comparison
Compare INSG & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- MIST
- Stock Information
- Founded
- INSG 1996
- MIST 2003
- Country
- INSG United States
- MIST Canada
- Employees
- INSG N/A
- MIST N/A
- Industry
- INSG Telecommunications Equipment
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- MIST Health Care
- Exchange
- INSG Nasdaq
- MIST Nasdaq
- Market Cap
- INSG 110.6M
- MIST 89.8M
- IPO Year
- INSG 2000
- MIST N/A
- Fundamental
- Price
- INSG $8.87
- MIST $1.89
- Analyst Decision
- INSG Buy
- MIST Strong Buy
- Analyst Count
- INSG 3
- MIST 2
- Target Price
- INSG $13.00
- MIST $7.50
- AVG Volume (30 Days)
- INSG 213.4K
- MIST 595.3K
- Earning Date
- INSG 08-06-2025
- MIST 08-07-2025
- Dividend Yield
- INSG N/A
- MIST N/A
- EPS Growth
- INSG N/A
- MIST N/A
- EPS
- INSG 0.31
- MIST N/A
- Revenue
- INSG $185,412,000.00
- MIST N/A
- Revenue This Year
- INSG N/A
- MIST N/A
- Revenue Next Year
- INSG $14.39
- MIST N/A
- P/E Ratio
- INSG $28.78
- MIST N/A
- Revenue Growth
- INSG 20.40
- MIST N/A
- 52 Week Low
- INSG $6.24
- MIST $0.63
- 52 Week High
- INSG $20.67
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- INSG 54.21
- MIST 67.15
- Support Level
- INSG $8.07
- MIST $1.85
- Resistance Level
- INSG $8.80
- MIST $2.02
- Average True Range (ATR)
- INSG 0.40
- MIST 0.09
- MACD
- INSG 0.11
- MIST 0.01
- Stochastic Oscillator
- INSG 64.05
- MIST 77.50
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).